Sort
130,381 grants matching “hiv”
HIV Vaccine Studies
$5,702,542Lesia Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
EXPANDING AND ENHANCING HIV VOLUNTARY COUNSELING AND TESTING SERVICES
$5,700,000Jan Andre Raats · Tebelopele Voluntary Cnsling/Testing Ctr · U62 · FY2008 · PS
Expanding and Intergrating HIV Care in Kenya
$5,700,000Ibrahim M Mohamed · National Aids/Sti Control Program · U2G · FY2006 · PS
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$5,692,974Jen Keagy · Ohio State Department Of Health · U62 · FY2013 · PS
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$5,685,406L. William Lyons · Georgia State Departmentof Public Health · U62 · FY2014 · PS
EXPANDED & INTEGRATED HIV TESTING FOR POPULATIONS DISPROPORTIONATELY AFFECTED BY
$5,683,949Monica Sweeney · New York City Health/Mental Hygiene · U62 · FY2009 · PS
REACH: Research Enterprise to Advance a Cure for HIV
$5,683,679R. Brad Jones · Weill Medical Coll Of Cornell Univ · UM1 · FY2021 · AI
BELIEVE: Bench to Bed Enhanced Lymphocyte Infusions to Engineer Viral Eradication
$5,680,664Douglas F Nixon · Weill Medical Coll Of Cornell Univ · UM1 · FY2020 · AI
Recipient Epidemiology and Donor Evaluation Study III (REDS-III) DCC
$5,680,497Donald Brambilla · Research Triangle Institute · N01 · FY2013 · HL
Immunologic and Virologic Basis of RhCMV/SIV Vaccine-Induced Replication Arrest Efficacy
$5,680,158Louis J. Picker · Oregon Health & Science University · P01 · FY2024 · AI
B and T Cell Biology of Protection from and Eradication of SIV/SHIV Infection
$5,678,616Eric Hunter · Emory University · UM1 · FY2025 · AI
B and T Cell Biology of Protection from and Eradication of SIV/SHIV Infection
$5,678,510Eric Hunter · Emory University · UM1 · FY2024 · AI
HIV VACCINE TRIALS NETWORK LEADERSHIP GROUP
$5,674,862Fred Hutchinson Cancer Research Center · U01 · FY2005 · AI
HPTN - CENTRAL LABORATORY
$5,673,285Johns Hopkins University · U01 · FY2004 · AI
Leadership for HIV/AIDS Clinical Trials Networks; HIV Prevention Trials Network
$5,673,078Deborah J Donnell · Fred Hutchinson Cancer Research Center · UM1 · FY2012 · AI
LC: HIV Prevention Trials Network
$5,668,821Susan H Eshleman · Johns Hopkins University · UM1 · FY2019 · AI
LC: HIV Prevention Trials Network
$5,663,547Susan H Eshleman · Johns Hopkins University · UM1 · FY2016 · AI
CoVPN 3004 - A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine LOC
$5,663,427Lawrence Corey · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
Acute HIV-1 Infections Network Core
$5,662,126John Andrew Crump · Duke University · U19 · FY2010 · AI
Laboratory Center (LC): Microbicide Trials Network
$5,656,261Lisa C Rohan · Magee-Women'S Res Inst And Foundation · UM1 · FY2019 · AI
PS10-1001, HIV PREVENTION PROJECTS
$5,652,941Linda Lesondak · Chicago Department Of Public Health · U62 · FY2011 · PS
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$5,646,163Jill Garland · Pennsylvania State Dept Of Health · U62 · FY2014 · PS
Core C: Vaccine production and process development
$5,637,003Lauren Carter · University Of Washington · U19 · FY2024 · AI
Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)
$5,636,888Mirko Paiardini · Emory University · UM1 · FY2023 · AI
Studies of Ocular Complications of AIDS - Coordinating Center
$5,629,490Curtis L Meinert · Johns Hopkins University · U10 · FY2010 · EY